Medical Research
(H30)
IRS Verified
DX Registered
990 on File
CHORDOMA FOUNDATION
Financial strength (30%)
91/100
Reliability (20%)
50/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
To improve the lives of those affected by chordoma and lead the search for a cure.
Financial Overview — FY 2023
$7.4M
Total Revenue
$4.6M
Total Expenses
$9.2M
Net Assets
12
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
83.2%
Fundraising Efficiency
N/A
Operating Reserve
24.04x
Liability-to-Asset
16.6%
Revenue Diversification
96.6%
Executive Compensation
$531K
Compared with Peers
FY 2023
Compared with 481 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
83.2% | 82.4% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
7.6% | 12.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
9.2% | 1.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
24.0 mo | 15.1 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
16.6% | 11.5% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
96.6% | 93.0% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
52.3% | 7.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
48.8% | 12.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
38.2% | 0.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $7.4M | $4.6M | $9.2M | 83.2% | 12 |
| 2022 | $4.9M | $3.1M | $6.2M | 75.0% | 11 |
| 2021 | $3.1M | $3.4M | N/A | — | 11 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.